Persistence Market Research Company
Customize Now Get FREE Sample

Newborn Metabolic Screening Market Size, Share, and Growth Forecast 2026 - 2033

Newborn Metabolic Screening Market by Test Type (Galactosemia, Sickle Cell Disease, Cystic Fibrosis, Toxoplasmosis, Phenylketonuria (PKU), Methylmalonic Acidemia, Maple Syrup Urine Disease (MSUD), Tyrosinemia), by Sample (Dried Blood Spot Sampling), by End User (Diagnostic Laboratories, Specialty Clinics, Hospitals), by Regional Analysis, 2026-2033

ID: PMRREP31998| 290 Pages | 19 Jan 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Newborn Metabolic Screening Market Snapshot 2026 and 2033
    2. Market Opportunity Assessment, 2026-2033, US$ Bn
    3. Key Market Trends
    4. Industry Developments and Key Market Events
    5. Demand Side and Supply Side Analysis
    6. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definitions
    2. Market Dynamics
      1. Driver
      2. Restraint
      3. Opportunities
      4. Trends
    3. Macro-Economic Factors
      1. Global GDP Outlook
      2. Global Healthcare Expenditure
    4. Forecast Factors – Relevance and Impact
    5. COVID-19 Impact Assessment
  3. Value Added Insights
    1. Value Chain analysis
    2. Key Market Players
    3. Test Adoption Analysis
    4. Key Promotional Strategies by key players
    5. PESTLE Analysis
    6. Porter's Five Forces Analysis
    7. Regulatory and Technology Landscape
  4. Global Newborn Metabolic Screening Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Global Newborn Metabolic Screening Market Outlook: Test Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Test Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Test Type, 2026-2033
        1. Galactosemia
        2. Sickle Cell Disease
        3. Cystic Fibrosis
        4. Toxoplasmosis
        5. Phenylketonuria (PKU)
        6. Methylmalonic Acidemia
        7. Maple Syrup Urine Disease (MSUD)
        8. Tyrosinemia
      4. Market Attractiveness Analysis: Test Type
    3. Global Newborn Metabolic Screening Market Outlook: Sample
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Sample, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Sample, 2026-2033
        1. Cylindrical Cells
        2. Prismatic Cells
        3. Button Cells
      4. Market Attractiveness Analysis: Sample
    4. Global Newborn Metabolic Screening Market Outlook: End User
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by End User, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by End User, 2026-2033
        1. Diagnostic Laboratories
        2. Specialty Clinics
        3. Hospitals
      4. Market Attractiveness Analysis: End User
  5. Global Newborn Metabolic Screening Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
    3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Newborn Metabolic Screening Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
    4. North America Market Size (US$ Bn) Forecast, by Test Type, 2026-2033
      1. Galactosemia
      2. Sickle Cell Disease
      3. Cystic Fibrosis
      4. Toxoplasmosis
      5. Phenylketonuria (PKU)
      6. Methylmalonic Acidemia
      7. Maple Syrup Urine Disease (MSUD)
      8. Tyrosinemia
    5. North America Market Size (US$ Bn) Forecast, by Sample, 2026-2033
      1. Cylindrical Cells
      2. Prismatic Cells
      3. Button Cells
    6. North America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Diagnostic Laboratories
      2. Specialty Clinics
      3. Hospitals
  7. Europe Newborn Metabolic Screening Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Europe Market Size (US$ Bn) Forecast, by Test Type, 2026-2033
      1. Galactosemia
      2. Sickle Cell Disease
      3. Cystic Fibrosis
      4. Toxoplasmosis
      5. Phenylketonuria (PKU)
      6. Methylmalonic Acidemia
      7. Maple Syrup Urine Disease (MSUD)
      8. Tyrosinemia
    5. Europe Market Size (US$ Bn) Forecast, by Sample, 2026-2033
      1. Cylindrical Cells
      2. Prismatic Cells
      3. Button Cells
    6. Europe Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Diagnostic Laboratories
      2. Specialty Clinics
      3. Hospitals
  8. East Asia Newborn Metabolic Screening Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    4. East Asia Market Size (US$ Bn) Forecast, by Test Type, 2026-2033
      1. Galactosemia
      2. Sickle Cell Disease
      3. Cystic Fibrosis
      4. Toxoplasmosis
      5. Phenylketonuria (PKU)
      6. Methylmalonic Acidemia
      7. Maple Syrup Urine Disease (MSUD)
      8. Tyrosinemia
    5. East Asia Market Size (US$ Bn) Forecast, by Sample, 2026-2033
      1. Cylindrical Cells
      2. Prismatic Cells
      3. Button Cells
    6. East Asia Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Diagnostic Laboratories
      2. Specialty Clinics
      3. Hospitals
  9. South Asia & Oceania Newborn Metabolic Screening Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of SAO
    4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Test Type, 2026-2033
      1. Galactosemia
      2. Sickle Cell Disease
      3. Cystic Fibrosis
      4. Toxoplasmosis
      5. Phenylketonuria (PKU)
      6. Methylmalonic Acidemia
      7. Maple Syrup Urine Disease (MSUD)
      8. Tyrosinemia
    5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Sample, 2026-2033
      1. Cylindrical Cells
      2. Prismatic Cells
      3. Button Cells
    6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Diagnostic Laboratories
      2. Specialty Clinics
      3. Hospitals
  10. Latin America Newborn Metabolic Screening Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of LATAM
    4. Latin America Market Size (US$ Bn) Forecast, by Test Type, 2026-2033
      1. Galactosemia
      2. Sickle Cell Disease
      3. Cystic Fibrosis
      4. Toxoplasmosis
      5. Phenylketonuria (PKU)
      6. Methylmalonic Acidemia
      7. Maple Syrup Urine Disease (MSUD)
      8. Tyrosinemia
    5. Latin America Market Size (US$ Bn) Forecast, by Sample, 2026-2033
      1. Cylindrical Cells
      2. Prismatic Cells
      3. Button Cells
    6. Latin America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Diagnostic Laboratories
      2. Specialty Clinics
      3. Hospitals
  11. Middle East & Africa Newborn Metabolic Screening Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Pricing Analysis
    3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. GCC Countries
      2. South Africa
      3. Northern Africa
      4. Rest of MEA
    4. Middle East & Africa Market Size (US$ Bn) Forecast, by Test Type, 2026-2033
      1. Galactosemia
      2. Sickle Cell Disease
      3. Cystic Fibrosis
      4. Toxoplasmosis
      5. Phenylketonuria (PKU)
      6. Methylmalonic Acidemia
      7. Maple Syrup Urine Disease (MSUD)
      8. Tyrosinemia
    5. Middle East & Africa Market Size (US$ Bn) Forecast, by Sample, 2026-2033
      1. Cylindrical Cells
      2. Prismatic Cells
      3. Button Cells
    6. Middle East & Africa Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Diagnostic Laboratories
      2. Specialty Clinics
      3. Hospitals
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
    3. Company Profiles
      1. PerkinElmer
        1. Company Overview
        2. Product Portfolio/Offerings
        3. Key Financials
        4. SWOT Analysis
        5. Company Strategy and Key Developments
      2. Bio-Rad Laboratories
      3. Trivitron Healthcare Private Limited
      4. BioMedomics, Inc.
      5. Luminex Corporation
      6. MP BIOMEDICALS
      7. Synergy Medical Systems LLP
      8. Agilent Technologies, Inc
      9. Thermo Fisher Scientific, Inc
      10. Zivak Technologies
      11. Covidien Plc
      12. AB Sciex LLC
      13. Waters Corp.
      14. Masimo Corp.
      15. Natus Medical Inc.
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate